ARTICLE | Clinical News
Vitae preclinical data
September 17, 2012 7:00 AM UTC
In primates, VTP-4 increased biomarkers of reverse cholesterol transport (RCT) at doses >=30 times lower than doses that cause triglyceride elevations in the plasma or liver, according to Vitae. The c...